{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:50:55Z","timestamp":1790787055443,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T00:00:00Z","timestamp":1596412800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T00:00:00Z","timestamp":1596412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Direction de la Recherche et de l'Innovation","award":["OST07013"],"award-info":[{"award-number":["OST07013"]}]},{"name":"Minist\u00e8re Fran\u00e7ais de la Recherche, Programme Hospitalier de Recherche Cliniqu","award":["AOM10165"],"award-info":[{"award-number":["AOM10165"]}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":[": COCAch (ERA-NET Neuron 2013, ANR-13"],"award-info":[{"award-number":[": COCAch (ERA-NET Neuron 2013, ANR-13"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["ADIKHUMICE (ERA-NET Neuron 2017, ANR-17-NEU3-0002-05"],"award-info":[{"award-number":["ADIKHUMICE (ERA-NET Neuron 2017, ANR-17-NEU3-0002-05"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"crossref","award":["COCACE (ERA-NET Neuron 2014, ANR R14026KK)"],"award-info":[{"award-number":["COCACE (ERA-NET Neuron 2014, ANR R14026KK)"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Labex BioPSY","award":["ANR-11-IDEX-0004-02"],"award-info":[{"award-number":["ANR-11-IDEX-0004-02"]}]},{"name":"Labex BioPSY","award":["ANR-11-IDEX-0004-02"],"award-info":[{"award-number":["ANR-11-IDEX-0004-02"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s00213-020-05620-x","type":"journal-article","created":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T23:04:34Z","timestamp":1596495874000},"page":"3399-3407","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Chronic exposure to cocaine is associated with persistent behavioral disturbances. A cross-sectional dimensional study in outpatients with multiple substance use disorders"],"prefix":"10.1007","volume":"237","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5168-3727","authenticated-orcid":false,"given":"Florence","family":"Vorspan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"de Witt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El-hadi","family":"Zerdazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Karsinti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamilia","family":"Ksouda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Icick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Bellivier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Marie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"Brousse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Bloch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,3]]},"reference":[{"key":"5620_CR1","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.pnpbp.2012.10.013","volume":"40","author":"S Allouche","year":"2013","unstructured":"Allouche S, Le Marec T, Noble F, Marie N (2013) Different patterns of administration modulate propensity of methadone and buprenorphine to promote locomotor sensitization in mice. Prog Neuropsychopharmacol Biol Psychiatry 40:286\u2013291. https:\/\/doi.org\/10.1016\/j.pnpbp.2012.10.013","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"5620_CR2","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1177\/070674370304800220","volume":"48","author":"FJ Bayl\u00e9","year":"2003","unstructured":"Bayl\u00e9 FJ, Krebs MO, Martin C, Bouvard MP, Wender P (2003) French version of Wender Utah rating scale (WURS). Can J Psychiatry Rev Can Psychiatr 48:132. https:\/\/doi.org\/10.1177\/070674370304800220","journal-title":"Can J Psychiatry Rev Can Psychiatr"},{"key":"5620_CR3","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.comppsych.2009.05.006","volume":"51","author":"HM Caci","year":"2010","unstructured":"Caci HM, Bouchez J, Bayl\u00e9 FJ (2010) An aid for diagnosing attention-deficit\/hyperactivity disorder at adulthood: psychometric properties of the French versions of two Wender Utah Rating Scales (WURS-25 and WURS-K). Compr Psychiatry 51:325\u2013331. https:\/\/doi.org\/10.1016\/j.comppsych.2009.05.006","journal-title":"Compr Psychiatry"},{"key":"5620_CR4","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/sj.bjp.0707195","volume":"151","author":"L Cordonnier","year":"2007","unstructured":"Cordonnier L, Sanchez M, Roques BP, Noble F (2007) Blockade of morphine-induced behavioral sensitization by a combination of amisulpride and RB101, comparison with classical opioid maintenance treatments. Br J Pharmacol 151:94\u2013102. https:\/\/doi.org\/10.1038\/sj.bjp.0707195","journal-title":"Br J Pharmacol"},{"key":"5620_CR5","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1146\/annurev.pu.17.050196.001355","volume":"17","author":"JW Cornish","year":"1996","unstructured":"Cornish JW, O\u2019Brien CP (1996) Crack cocaine abuse: an epidemic with many public health consequences. Annu Rev Public Health 17:259\u2013273. https:\/\/doi.org\/10.1146\/annurev.pu.17.050196.001355","journal-title":"Annu Rev Public Health"},{"key":"5620_CR6","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1111\/j.1521-0391.2013.12047.x","volume":"22","author":"C Daigre","year":"2013","unstructured":"Daigre C, Roncero C, Grau-L\u00f3pez L, Mart\u00ednez-Luna N, Prat G, Valero S, Tejedor R, Ramos-Quiroga JA, Casas M (2013) Attention deficit hyperactivity disorder in cocaine-dependent adults: a psychiatric comorbidity analysis. Am J Addict 22:466\u2013473. https:\/\/doi.org\/10.1111\/j.1521-0391.2013.12047.x","journal-title":"Am J Addict"},{"key":"5620_CR7","doi-asserted-by":"publisher","first-page":"e1372","DOI":"10.4088\/JCP.12m07895","volume":"73","author":"E Dakwar","year":"2012","unstructured":"Dakwar E, Mahony A, Pavlicova M, Glass A, Brooks D, Mariani JJ, Grabowski J, Levin FR (2012) The utility of attention-deficit\/hyperactivity disorder screening instruments in individuals seeking treatment for substance use disorders. J Clin Psychiatry 73:e1372\u2013e1378. https:\/\/doi.org\/10.4088\/JCP.12m07895","journal-title":"J Clin Psychiatry"},{"key":"5620_CR8","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1097\/ADM.0b013e31821b4038","volume":"5","author":"H Delavenne","year":"2011","unstructured":"Delavenne H, Ballon N, Charles-Nicolas A, Garcia FD, Thibaut F, Lacoste J, Local Research Ethics Committee (2011) Attention deficit hyperactivity disorder is associated with a more severe pattern of cocaine consumption in cocaine users from French West Indies. J Addict Med 5:284\u2013288. https:\/\/doi.org\/10.1097\/ADM.0b013e31821b4038","journal-title":"J Addict Med"},{"key":"5620_CR9","volume-title":"European Drug Report 2019: Trends and Developments, Publications Office of the European","author":"EMCDDA European Monitoring Centre for Drugs and Drug Addiction","year":"2019","unstructured":"EMCDDA European Monitoring Centre for Drugs and Drug Addiction (2019) European Drug Report 2019: Trends and Developments, Publications Office of the European. Union, Luxembourg https:\/\/www.emcdda.europa.eu\/system\/files\/publications\/11364\/20191724_TDAT19001ENN_PDF.pdf"},{"key":"5620_CR10","doi-asserted-by":"publisher","first-page":"164","DOI":"10.30773\/pi.2017.05.14.1","volume":"15","author":"C Evren","year":"2018","unstructured":"Evren C, Alniak I, Karabulut V, Cetin T, Umut G, Agachanli R, Evren B (2018) Relationship of probable attention deficit hyperactivity disorder with severity of psychopathology and impulsivity in a sample of male patients with opioid use disorder. Psychiatry Investig 15:164\u2013171. https:\/\/doi.org\/10.30773\/pi.2017.05.14.1","journal-title":"Psychiatry Investig"},{"key":"5620_CR11","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1192\/bjp.bp.106.034389","volume":"190","author":"J Fayyad","year":"2007","unstructured":"Fayyad J, De Graaf R, Kessler R, Alonso J, Angermeyer M, Demyttenaere K, De Girolamo G, Haro JM, Karam EG, Lara C, L\u00e9pine J-P, Ormel J, Posada-Villa J, Zaslavsky AM, Jin R (2007) Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry J Ment Sci 190:402\u2013409. https:\/\/doi.org\/10.1192\/bjp.bp.106.034389","journal-title":"Br J Psychiatry J Ment Sci"},{"key":"5620_CR12","first-page":"295","volume":"58","author":"AB Hill","year":"1965","unstructured":"Hill AB (1965) The environment and disease: association or causation? Proc R Soc Med 58:295\u2013300","journal-title":"Proc R Soc Med"},{"key":"5620_CR13","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/j.1749-6632.1992.tb25961.x","volume":"654","author":"PW Kalivas","year":"1992","unstructured":"Kalivas PW, Striplin CD, Steketee JD, Klitenick MA, Duffy P (1992) Cellular mechanisms of behavioral sensitization to drugs of abuse. Ann N Y Acad Sci 654:128\u2013135. https:\/\/doi.org\/10.1111\/j.1749-6632.1992.tb25961.x","journal-title":"Ann N Y Acad Sci"},{"key":"5620_CR14","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.drugalcdep.2014.08.008","volume":"144","author":"S Kaye","year":"2014","unstructured":"Kaye S, Gilsenan J, Young JT, Carruthers S, Allsop S, Degenhardt L, van de Glind G, van den Brink W (2014) Risk behaviours among substance use disorder treatment seekers with and without adult ADHD symptoms. Drug Alcohol Depend 144:70\u201377. https:\/\/doi.org\/10.1016\/j.drugalcdep.2014.08.008","journal-title":"Drug Alcohol Depend"},{"key":"5620_CR15","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s00213-011-2223-6","volume":"216","author":"T Le Marec","year":"2011","unstructured":"Le Marec T, Marie-Claire C, Noble F, Marie N (2011) Chronic and intermittent morphine treatment differently regulates opioid and dopamine systems: a role in locomotor sensitization. Psychopharmacology (Berl) 216:297\u2013303. https:\/\/doi.org\/10.1007\/s00213-011-2223-6","journal-title":"Psychopharmacology (Berl)"},{"key":"5620_CR16","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.drugalcdep.2018.03.043","volume":"188","author":"FR Levin","year":"2018","unstructured":"Levin FR, Choi CJ, Pavlicova M, Mariani JJ, Mahony A, Brooks DJ, Nunes EV, Grabowski J (2018) How treatment improvement in ADHD and cocaine dependence are related to one another: a secondary analysis. Drug Alcohol Depend 188:135\u2013140. https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.03.043","journal-title":"Drug Alcohol Depend"},{"key":"5620_CR17","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1521-0391.2013.12086.x","volume":"23","author":"JJ Mariani","year":"2014","unstructured":"Mariani JJ, Khantzian EJ, Levin FR (2014) The self-medication hypothesis and psychostimulant treatment of cocaine dependence: an update. Am J Addict 23:189\u2013193. https:\/\/doi.org\/10.1111\/j.1521-0391.2013.12086.x","journal-title":"Am J Addict"},{"key":"5620_CR18","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1080\/15563650.2018.1549735","volume":"57","author":"\u00d2 Mir\u00f3","year":"2019","unstructured":"Mir\u00f3 \u00d2, Dargan PI, Wood DM, Dines AM, Yates C, Heyerdahl F, Hovda KE, Giraudon I, Euro-DEN Plus Research Group, Galicia M (2019) Epidemiology, clinical features and management of patients presenting to European emergency departments with acute cocaine toxicity: comparison between powder cocaine and crack cocaine cases. Clin Toxicol Phila Pa 57:718\u2013726. https:\/\/doi.org\/10.1080\/15563650.2018.1549735","journal-title":"Clin Toxicol Phila Pa"},{"key":"5620_CR19","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1159\/000336219","volume":"45","author":"E Peles","year":"2012","unstructured":"Peles E, Schreiber S, Sutzman A, Adelson M (2012) Attention deficit hyperactivity disorder and obsessive-compulsive disorder among former heroin addicts currently in methadone maintenance treatment. Psychopathology 45:327\u2013333. https:\/\/doi.org\/10.1159\/000336219","journal-title":"Psychopathology"},{"key":"5620_CR20","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.psychres.2009.03.019","volume":"185","author":"J P\u00e9rez de Los Cobos","year":"2011","unstructured":"P\u00e9rez de Los Cobos J, Si\u00f1ol N, Puerta C, Cantillano V, L\u00f3pez Zurita C, Trujols J (2011) Features and prevalence of patients with probable adult attention deficit hyperactivity disorder who request treatment for cocaine use disorders. Psychiatry Res 185:205\u2013210. https:\/\/doi.org\/10.1016\/j.psychres.2009.03.019","journal-title":"Psychiatry Res"},{"key":"5620_CR21","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.encep.2009.12.005","volume":"36","author":"L Romo","year":"2010","unstructured":"Romo L, Legauffre C, Mille S, Ch\u00e8ze N, Foug\u00e8res A-L, Marquez S, Excoffier A, Dubertret C, Ad\u00e8s J (2010) Psychometric properties of the French version of the Wender Utah Rating Scale and Brown\u2019s Attention Deficit Disorders Scale for adults. L\u2019Encephale 36:380\u2013389. https:\/\/doi.org\/10.1016\/j.encep.2009.12.005","journal-title":"L\u2019Encephale"},{"key":"5620_CR22","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.drugalcdep.2013.04.010","volume":"132","author":"G van de Glind","year":"2013","unstructured":"van de Glind G, van den Brink W, Koeter MWJ, Carpentier P-J, van Emmerik-van Oortmerssen K, Kaye S, Skutle A, Bu E-TH, Franck J, Konstenius M, Moggi F, Dom G, Verspreet S, Demetrovics Z, Kapit\u00e1ny-F\u00f6v\u00e9ny M, Fats\u00e9as M, Auriacombe M, Schillinger A, Seitz A, Johnson B, Faraone SV, Ramos-Quiroga JA, Casas M, Allsop S, Carruthers S, Barta C, Schoevers RA, IASP Research Group, Levin FR (2013) Validity of the Adult ADHD Self-Report Scale (ASRS) as a screener for adult ADHD in treatment seeking substance use disorder patients. Drug Alcohol Depend 132:587\u2013596. https:\/\/doi.org\/10.1016\/j.drugalcdep.2013.04.010","journal-title":"Drug Alcohol Depend"},{"key":"5620_CR23","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1176\/ajp.150.6.885","volume":"150","author":"MF Ward","year":"1993","unstructured":"Ward MF, Wender PH, Reimherr FW (1993) The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychiatry 150:885\u2013890. https:\/\/doi.org\/10.1176\/ajp.150.6.885","journal-title":"Am J Psychiatry"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-020-05620-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-020-05620-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-020-05620-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T23:21:55Z","timestamp":1627946515000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-020-05620-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,3]]},"references-count":23,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["5620"],"URL":"https:\/\/doi.org\/10.1007\/s00213-020-05620-x","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,3]]},"assertion":[{"value":"14 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Both studies were conducted according to French laws on bioethics. Patients were required to be free of unstable psychiatric conditions and to give free and informed written consent. Both studies were approved by local ethics committees (CPP IDF VI and CPP IDF IV respectively).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"In the last 3 years, outside of the submitted work, FV has received research grants from the Programme Hospitalier de Recherche Clinique from the French Ministry of Health (PHRC National PHRC-N-18-07777), the Fondation pour la Recherche en Alcoologie (Fondation de France), and congress fees from Camurus AB. RI has received honorarium by Pierre Fabre, which was given in full to a non-lucrative association, and honoraria from Lundbeck for giving talks. FB has received honoraria or research or educational conference grants from Bristol-Myers Squibb, Otsuka, Eli Lilly & Co., Servier, Takeda, Sanofi Aventis, Lundbeck, AstraZeneca, and the European Space Agency and has received peer review research funding from the Ministry of Research, Assistance Publique\u2013H\u00f4pitaux de Paris, the National Institute for Research (INSERM), and the NARSAD, outside the submitted work. GB has received research grants from Agence Nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de Sant\u00e9 (ANSM) and Institut de Recherche en Sant\u00e9 Publique (IRESP) and congress fees from Camurus, Indivior, and Bouchara. Other authors have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Those agencies had no further role in study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}